# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Bernstein analyst Lisa Clive downgrades Smith & Nephew (NYSE:SNN) from Outperform to Market Perform and announces $37.5 ...
Smith+Nephew (NYSE:SNN, LSE:SN))), the global medical technology business, is pleased to announce exciting new data from Profes...
The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...
Canaccord Genuity analyst Caitlin Cronin maintains Smith & Nephew (NYSE:SNN) with a Hold and raises the price target fro...